Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 16/20 | 0.57 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27701616 | 0.88 | HDAC1 (0.56) | HDAC1 | |
| SCHEMBL27722213 | 0.84 | HDAC1 (0.52) | HDAC1ALDH1A1 | |
| SCHEMBL27722204 | 0.79 | HDAC1 (0.44) | HDAC1 | |
| SCHEMBL27701912 | 0.78 | HDAC1 (0.49) | HDAC1 | |
| SCHEMBL27701769 | 0.78 | KDM4E (0.41) | HDAC1NR1H4KDM4EALDH1A1RAB9A | |
| SCHEMBL27701800 | 0.77 | HDAC1 (0.42) | HDAC1 | |
| SCHEMBL27701637 | 0.77 | HDAC1 (0.42) | HDAC1KDM4EALDH1A1RAB9A | |
| SCHEMBL27701722 | 0.76 | HDAC1 (0.41) | HDAC1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL27701631 | 0.75 | HDAC1 (0.42) | HDAC1 | |
| SCHEMBL27701696 | 0.74 | HDAC1 (0.41) | HDAC1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101163703-B | Imidazo [1,2-A ] pyridine derivatives as Peptide Deformylase (PDF) inhibitors | NOVARTIS AG | 2010-12-15 | — | — | CN | disclosed |
| CN-101163703-A | Imidazo [1, 2-A ] pyridine derivatives as Peptide Deformylase (PDF) inhibitors | NOVARTIS AG (CH) | 2008-04-16 | — | — | CN | disclosed |